These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35233290)

  • 1. When speed matters: a discussion on the benefits of a grace period in patent law to accelerate pharmaceutical innovation in times of pandemic.
    Ozyhar T; Barnabei L; Myrick D
    J Law Biosci; 2022; 9(1):lsac004. PubMed ID: 35233290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patenting inventions in the field of biology and chemistry: German and European patent law and case law.
    Vossius V
    Naturwissenschaften; 1997 Oct; 84(10):431-43. PubMed ID: 9394296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inventions and Patents: A Practical Tutorial.
    Mehta H; Tidwell L; Liotta LA
    Methods Mol Biol; 2017; 1606():379-397. PubMed ID: 28502014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical technology transfer: the inventor's perspective.
    Marks LA
    Biomed Instrum Technol; 1991; 25(1):35-41. PubMed ID: 2004192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMPULSORY LICENSING IN CONTEXT OF THE COVID-19 PANDEMIC AS A TOOL FOR ENSURING THE BALANCE BETWEEN RIGHTS-HOLDERS' AND SOCIETY'S INTERESTS.
    Chepys O
    Georgian Med News; 2020 Nov; (308):160-165. PubMed ID: 33395660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Economic Theory of Patent Protection and Pandemic Influenza Vaccines: Do Patents Really Incentivize Innovation in the Field?
    Eccleston-Turner M
    Am J Law Med; 2016 May; 42(2-3):572-597. PubMed ID: 29086638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patents and ethics: is it possible to be balanced?
    Spławiński J
    Sci Eng Ethics; 2005 Jan; 11(1):71-4. PubMed ID: 15727001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The COVID-19 pandemic and long-term incentives for developing vaccines: Patent law under stress.
    Kovac M; Rakovec L
    J World Intellect Prop; 2022 Mar; ():. PubMed ID: 35600091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective Strategies to Patent Plastic Surgery Ideas and Intellectual Property.
    Xu HH; Kazan R; Zammit D; Reece E; Jowett N; Gilardino MS; Vorstenbosch J
    Plast Reconstr Surg; 2023 May; 151(5):875e-884e. PubMed ID: 36728928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
    Siri JGS; Fernando CAN; De Silva SNT
    Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic Patenting by Pharmaceutical Companies - Should Competition Law Intervene?
    Gurgula O
    IIC Int Rev Ind Prop Copyr Law; 2020; 51(9):1062-1085. PubMed ID: 33132411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summoning a New Artificial Intelligence Patent Model: In The Age Of Pandemic.
    Yanisky-Ravid S; Jin R
    SSRN; 2020 Jun; ():3619069. PubMed ID: 32714121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the written description requirement to limit broad patent scope, allow competition, and encourage innovation in biotechnology.
    Mull WC
    Health Matrix Clevel; 2004; 14(2):393-435. PubMed ID: 15503695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open Innovation or Traditional Patenting Strategies to Efficiently Address Health Emergencies? How Patent Information Was Used Towards Effective Treatments for COVID-19.
    de Almeida TDME; Cordeiro DS
    Recent Pat Biotechnol; 2024 Jun; ():. PubMed ID: 38910270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents.
    Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL; Beyer A; Visaria J
    Food Drug Law J; 2009; 64(1):171-81. PubMed ID: 19998745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To be or not IP? Exploring limits within patent law for the constitutionalization of intellectual property rights and the governance of synthetic biology in human health.
    Schneider I
    Rev Derecho Genoma Hum; 2012; (37):193-233. PubMed ID: 23520920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A concise framework to facilitate open COVID pledge of non-disclosed technologies: In terms of non-disclosed patent applications and trade secrets.
    Wang RL; Shen CL; Wu TC; Hsiao WW
    J Formos Med Assoc; 2022 Aug; 121(8):1425-1430. PubMed ID: 34756502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
    Jannuzzi AH; Vasconcellos AG; de Souza CG
    Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scientific journals and their authors' financial interests: a pilot study.
    Krimsky S; Rothenberg LS; Stott P; Kyle G
    Psychother Psychosom; 1998; 67(4-5):194-201. PubMed ID: 9693346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.